Home / FlashMed

FlashMed

Titolo Dry-Weight Reduction in Hypertensive Hemodialysis Patients (DRIP) - A Randomized, Controlled Trial
Autore Rajiv Agarwal, Pooneh Alborzi, Sangeetha Satyan, Robert P. Light
Referenza Hypertension 2009; DOI: 10.1161/HYPERTENSIONAHA.108.125674
Contenuto Abstract?Volume excess is thought to be important in the pathogenesis of hypertension among hemodialysis patients. To determine whether additional volume reduction will result in improvement in blood pressure (BP) among hypertensive patients on hemodialysis and to evaluate the time course of this response, we randomly assigned long-term hypertensive hemodialysis patients to ultrafiltration or control groups. The additional ultrafiltration group (n_100) had the dry weight probed without increasing time or duration of dialysis, whereas the control group (n_50) only had physician visits. The primary outcome was change in systolic interdialytic ambulatory BP. Postdialysis weight was reduced by 0.9 kg at 4 weeks and resulted in _6.9 mm Hg (95% CI: _12.4 to _1.3 mm Hg; P_0.016) change in systolic BP and _3.1 mm Hg (95% CI: _6.2 to _0.02 mm Hg; P_0.048) change in diastolic BP. At 8 weeks, dry weight was reduced 1 kg, systolic BP changed _6.6 mm Hg (95% CI: _12.2 to _1.0 mm Hg; P_0.021), and diastolic BP changed _3.3 mm Hg (95% CI: _6.4 to _0.2 mm Hg; P_0.037) from baseline. The Mantel-Hanzel combined odds ratio for systolic BP reduction of _10 mm Hg was 2.24 (95% CI: 1.32 to 3.81; P_0.003). There was no deterioration seen in any domain of the kidney disease quality of life health survey despite an increase in intradialytic signs and symptoms of hypotension. The reduction of dry weight is a simple, efficacious, and well-tolerated maneuver to improve BP control in hypertensive hemodialysis patients. Long-term control of BP will depend on continued assessment and maintenance of dry weight.
Data 05.02.2009
 
Maggiori informazioni   
Lista completa